Sunday December 15, 2019
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Asia 2020
    • |BioProcess International US West
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

2005

Vaccine Manufacturing Case Study

by BPI Contributor
Add Comment
July 1, 2005

RP-HPLC Preparative MODcol® SPRING COLUMN® Purification of rHu-Insulin and Characterization of Impurities By Capillary LC-MS

by BPI Contributor
Add Comment
July 1, 2005

Precipitates in Serum Products

by BPI Contributor
Add Comment
July 1, 2005

Production of Poliovirus Using Vero Cells Cultured in HyQ® SFM4MegaVir™ with Nunc Cell Factories, T-Flasks, and Roller Bottles

by BPI Contributor
Add Comment
July 1, 2005

Transforming the Outer Limits of Tangential Flow Filtration

by BPI Contributor
Add Comment
July 1, 2005

Synthetic Peptide Purification: The Benefits of Using Rigid Polymeric Packings

by BPI Contributor
Add Comment
July 1, 2005

Planova® 20N Virus Filter Effectively Removes Porcine Parvovirus from Concentrated MAb Solutions

by BPI Contributor
Add Comment
July 1, 2005

AMBERCHROM™ HPR10, Reversed Phase Chromatographic Resin for Final Polishing Applications: Superior Performance with Full CIP Capability

by BPI Contributor
Add Comment
July 1, 2005

Adaptation of Cells into BD CHO Medium Without L-Glutamine

by BPI Contributor
Add Comment
July 1, 2005

Seeing the Forest and the Trees: The Optimal Way to Successful Development

by BPI Contributor
Add Comment
July 1, 2005
  • <
  • 1
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ...
  • 23
  • >

Editor’s Choice

  • BioProcess Insider

    $50m deal helps make Sartorius a media player again

  • BioProcess Insider

    Astellas: Large-scale gene therapy plant major driver in $3bn Audentes deal

  • Sponsored Content

    The Road to Commercialization: A Commercial CDMO’s Perspective

  • BioProcess Insider

    Blame the messenger: Novartis cites RNAi candidate in $9.7bn Medicines Company deal

  • BioProcess Insider

    China: Stainless-steel will shine as market moves to commercial

  • Sponsored Content

    Matrix: The Highly Automated Multibioreactor Solution That Fits to Your Bench Space, Bioprocessing Needs, and Budget

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: The US Government has contracted Sanofi Pasteur to increase recombinant #vaccine capacity at its Pennsylvania plant… https://t.co/hWSs4TUnZT 2 days ago
  • Tweet Avatar RT @BioProcessIntl: Webcast: "Best Practices for Aseptic Sampling from Stainless Process Equipment" December 19th, 2019 at 11:00 AM ET… https://t.co/lsbrHcpwBy 2 days ago
  • Tweet Avatar RT @Dan5tanton: A single-use bioprocessing training facility in Guangzhou will help attract and retain biopharma talent in the burg… https://t.co/IaN6DEcrwB 4 days ago
  • Tweet Avatar RT @Dan5tanton: @Amazon says Novartis’ personalized medicines operations will benefit from AI and machine learning collaboration. https://t.co/ckQrFpJ4aX 4 days ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    MilliporeSigma: Over 90% growth comes from mAbs, despite new modality momentum

  • BioProcess Insider

    Fujifilm pumps $120m into US gene therapy development and manufacturing

  • BioProcess Insider

    $50m deal helps make Sartorius a media player again

  • BioProcess Insider

    Purolite resin booming on biopharma uptake and ‘major’ regulatory milestone

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2019 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International Asia 2020
    • BioProcess International US West
  • BioProcess International Academy
  • Events